.1

Overview of B&W Medical Isotope Production System

Foundation for Nuclear Studies

September 27, 2011

Steve SchilthelmDeputy Program Manager

.2

The Babcock & Wilcox CompanyGovernment Operations Power Generation Systems

High-Consequence Operations & Services

Advanced Engineering and Manufacturing

Manufactures and services coal, biomass, CNG, concentrated solar power plant equipment, & Nox, Sox, mercury scrubbers

Manufactures nuclear components for U.S. Department of Energy

Manufactures commercial nuclear components and provides services to commercial nuclear market

Manages and operates high-consequence facilities, provides technical services and support to government agencies and private customers

B&W NuclearOperations Group, Inc.

B&W Power Generation Group, Inc.

B&W NuclearEnergy , Inc.

B&W TechnicalServices Group, Inc.

.3

Covidien Reach Extends Globally and Locally

Diverse healthcare products used in all clinical settings

20,000+ U.S. employees, 41,000+ worldwide

Products manufactured in17 states

Covidien Tc 99m-based products sold in all 50 states

Nuclear Medicine:

One of two U.S. suppliers oftechnetium 99m (Tc 99m)

Image used by permission of Covidien

.4

B&W MIPS – 99Mo Production Using Aqueous Homogeneous Reactor

Market studies in Late 1990s Patented in 1997 (Dr. Russell M. Ball)

2007 MIPS project re-initiated 2009 Agreement with Covidien 2009 Cooperative Agreement with NNSA

Non-proliferation (LEU)

Domestic supply

AHR using LEU offers safety, safeguards, simplicity and waste advantages

.5

Over 30 AHRs Built and Operated

AHRs are not New Technology

CLEVELAND, OHCLEVELAND, OH

SHEBA Reactor, LANL

.6

AHR - America’s First University Reactor

N.C. State’s – R1 (1953-73)

.7

Dissolved Target Waste with 235U

Traditional Technology235U Target Fabrication

Target Irradiation: Several days Reactor: 10,000 -100,000 kilowatts

Transport

99mTc Generator Facility

Tran

spor

t

Transport

99Mo Processing Facility

99mTc User Medical Facilities

Transpo

rt

.8

B&W MIPS Technology

Transp

o

rt

99mTc User Medical Facilities

99mTc Generator Facility

AHR Reactor 240 kilowatts- 5 days

Reactor fuel/target solution returned for subsequent irradiation

Initial Fuel Solution Preparation

MIPS Facility

99Mo Processing Cells

Tran

spo

rt

.9

Completing R&D Phase of Project

National Laboratories Argonne

Los Alamos

Armed Forces Radiobiology Research Institute, MD

Purdue University

B&W Labs, VA

INVAP, Argentina

.10

MIPS Project Progress

Conceptual design complete NRC licensing and waste policy decisions

complete Environmental analysis prepared Completing R&D activities Following legislation (HR 3276, S 99) Entering detailed design and licensing phase of

the project

.11

B&W MIPS Summary

Mo-99 production using LEU AHR results in:

Increased efficiencyReduced waste No proliferation concernsSafe operationStable domestic supply